Intellia pauses two late-stage CRISPR gene-editing trials after emergence of safety concern Treated patient is hospitalized with liver damage, a known risk of therapy

https://www.statnews.com/2025/10/27/intellia-gene-editing-trial-pause/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_CAc2dIjB0vDZnktLVYdUHttI29FxjK1qqzZMcnuEpGZ_-bsTIyd6RNBLeKaMlj3Y848eJ4k4xqbYjm5nxiQp2dnHjXg&_hsmi=387101212&utm_content=387101212&utm_source=hs_email